Cite
HARVARD Citation
Iwama, E. et al. (2022). Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations. European journal of cancer. pp. 99-106. [Online].